Delaware
|
| |
6770
|
| |
86-1370703
|
(State or other jurisdiction of incorporation or organization)
|
| |
(Primary Standard Industrial Classification Code Number)
|
| |
(I.R.S. Employer Identification No.)
|
Christian O. Nagler
Brooks W. Antweil
Kirkland & Ellis LLP
601 Lexington Avenue
New York, NY 10022
(212) 446-4800
|
| |
Frank Lopez
Jonathan Ko
James M. Shea, Jr.
Paul Hastings LLP
200 Park Avenue
New York, New York 10166
(212) 318-6000
|
Large accelerated filer ☐
|
| |
Accelerated filer ☐
|
Non-accelerated filer ☒
|
| |
Smaller reporting company ☒
|
|
| |
Emerging growth company ☒
|
Title of Each Class of Security Being Registered
|
| |
Amount
Being Registered
|
| |
Proposed Maximum
Offering Price
per Security(1)
|
| |
Proposed Maximum
Aggregate
Offering Price(1)
|
| |
Amount of
Registration Fee
|
Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-third of one redeemable warrant(2)
|
| |
23,000,000 Units
|
| |
$10.00
|
| |
$230,000,000
|
| |
$25,093
|
Shares of Class A common stock included as part of the units(3)
|
| |
23,000,000 Shares
|
| |
—
|
| |
—
|
| |
—(4)
|
Redeemable warrants included as part of the units(3)
|
| |
7,666,667 Warrants
|
| |
—
|
| |
—
|
| |
—(4)
|
Shares of Class A common stock underlying redeemable warrants(3)
|
| |
7,666,667 Shares
|
| |
$11.50
|
| |
$88,166,670.50
|
| |
$9,619
|
Total
|
| |
|
| |
|
| |
$318,166,670.50
|
| |
$34,712
|
(1)
|
Estimated solely for the purpose of calculating the registration fee.
|
(2)
|
Includes 3,000,000 units, consisting of 3,000,000 shares of Class A common stock and 1,000,000 redeemable warrants, which may be issued upon exercise of a 45-day option granted to the underwriters to cover over-allotments, if any.
|
(3)
|
Pursuant to Rule 416 under the Securities Act, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.
|
(4)
|
No fee pursuant to Rule 457(g) under the Securities Act.
|
|
| |
Per Unit
|
| |
Total
|
Public offering price
|
| |
$10.00
|
| |
$200,000,000
|
Underwriting discounts and commissions(1)
|
| |
$0.55
|
| |
$11,000,000
|
Proceeds, before expenses, to Software Acquisition Group Inc. III
|
| |
$9.45
|
| |
$189,000,000
|
(1)
|
$0.20 per unit, or $4,000,000 in the aggregate (or $4,600,000 if the underwriters’ over-allotment option is exercised in full), is payable upon the closing of this offering. Includes $0.35 per unit, or $7,000,000 (or up to $8,050,000 if the underwriters’ over-allotment option is exercised in full) in the aggregate payable to the underwriters for deferred underwriting commissions to be placed in a trust account located in the United States as described herein. The deferred commissions will be released to the underwriters only on completion of an initial business combination, as described in this prospectus. See the section of this prospectus entitled “Underwriting” beginning on page 149 for a description of underwriting compensation payable to the underwriters.
|
|
| |
|
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| | ||
| |
⯀
|
“common stock” are to our Class A common stock and our Class B common stock, collectively;
|
⯀
|
“founder shares” are to shares of our Class B common stock held by our initial stockholders prior to this offering, and the shares of our Class A common stock issued upon the conversion thereof as provided herein;
|
⯀
|
“initial stockholders” are to our sponsor and any other holders of our founder shares prior to this offering (or their permitted transferees);
|
⯀
|
“management” or our “management team” are to our officers and directors (including our director nominees who will become directors upon consummation of this offering);
|
⯀
|
“private placement warrants” are to the warrants issued to our sponsor in a private placement simultaneously with the closing of this offering;
|
⯀
|
“public shares” are to shares of our Class A common stock sold as part of the units in this offering (whether they are purchased in this offering or thereafter in the open market);
|
⯀
|
“public stockholders” are to the holders of our public shares, including our initial stockholders and members of our management team to the extent our initial stockholders and/or members of our management team purchase public shares; provided that each initial stockholder’s and member of our management team’s status as a “public stockholder” shall only exist with respect to such public shares;
|
⯀
|
“public warrants” are to our redeemable warrants sold as part of the units in this offering (whether they are purchased in this offering or thereafter in the open market), to the private placement warrants if held by third parties other than our sponsor (or permitted transferees), and to any private placement warrants issued upon conversion of working capital loans that are sold to third parties that are not initial purchasers of our private placement warrants or executive officers or directors (or permitted transferees);
|
⯀
|
“sponsor” are to Software Acquisition Holdings III LLC, a Delaware limited liability company affiliated with Jonathan Huberman, our Chairman, Chief Executive Officer and Chief Financial Officer, Mike Nikzad, our Vice President of Acquisitions and Andrew Nikou, one of our directors;
|
⯀
|
“trust account” are to the trust account in the United States at J.P. Morgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company acting as trustee, into which we will deposit certain proceeds from this offering and the sale of the private placement warrants;
|
⯀
|
“warrants” are to our redeemable warrants, which includes the public warrants as well as the private placement warrants to the extent they are no longer held by the initial purchaser of the private placement warrants or its permitted transferees; and
|
⯀
|
“we,” “us,” “our,” “company” or “our company” are to Software Acquisition Group Inc. III.
|
⯀
|
Investing in private and public technology companies to accelerate their growth and maturation;
|
⯀
|
Sourcing, structuring, acquiring, and selling businesses;
|
⯀
|
Accessing the capital markets; and
|
⯀
|
Fostering relationships with sellers, capital providers and target management teams.
|
⯀
|
Large and growing market. We will focus on investments in industry segments that we believe demonstrate attractive long-term growth prospects and reasonable overall size or potential;
|
⯀
|
Attractive, inherently profitable business with high operating leverage. We will seek to invest in companies that we believe possess not only established business models and sustainable competitive advantages, but also inherently profitable unit economics;
|
⯀
|
Strong management teams. We will spend significant time assessing a company’s leadership and personnel and evaluating what we can do to augment and/or upgrade the team over time if needed;
|
⯀
|
Opportunity for operational improvements. We will seek to identify businesses that we believe are stable but at an inflection point and would benefit from our ability to drive improvements in the company’s processes, go-to-market strategy, product or service offering, sales and marketing efforts, geographical presence and/or leadership team;
|
⯀
|
Differentiated products or services. We will evaluate metrics such as recurring revenues, product life cycle, cohort consistency, pricing per product or customer, cross-sell success and churn rates to focus on businesses whose products or services are differentiated or where we see an opportunity to create value by implementing best practices;
|
⯀
|
Compelling growth prospects. We view growth as an important driver of value and will seek companies whose growth potential can generate meaningful upside;
|
⯀
|
Limited technology risk. We will seek to invest in companies that have established market-tested product or service offerings;
|
⯀
|
Appropriate valuations. We will seek to be a disciplined and valuation-centric investor that will invest on terms that we believe provide significant upside potential with limited downside risk; and
|
⯀
|
Benefit from Being a Public Company. We intend to pursue a business combination with a company that we believe will benefit from being publicly traded and can effectively utilize the broader access to capital and public profile that are associated with being a publicly traded company.
|
⯀
|
Management team’s industry knowledge and contacts.
|
⯀
|
Deal flow and business development resources available to our sponsor and its affiliates.
|
⯀
|
Management team’s experience and reputation in sourcing opportunities.
|
⯀
|
Extensive relationships within the private equity community (a likely source of deal flow).
|
⯀
|
Management team’s demonstrated ability to create value for their shareholders.
|
⯀
|
Strong track record of operational excellence.
|
⯀
|
one share of Class A common stock; and
|
⯀
|
one-third of one redeemable warrant.
|
(1)
|
Assumes no exercise of the underwriters’ over-allotment option and the forfeiture by our sponsor of an aggregate of 750,000 founder shares.
|
(2)
|
Includes up to an aggregate of 750,000 shares that are subject to forfeiture by our sponsor depending on the extent to which the underwriters’ over-allotment option is exercised.
|
(3)
|
Comprised of 20,000,000 shares of Class A common stock and 5,000,000 shares of Class B common stock. The Class B common stock is convertible into shares of our Class A common stock on a one-for-one basis, subject to adjustment as described herein adjacent to the caption “Founder shares conversion and anti-dilution rights.”
|
⯀
|
in whole and not in part;
|
⯀
|
at a price of $0.01 per warrant;
|
⯀
|
upon a minimum of 30 days’ prior written notice of redemption, which we refer to as the 30-day redemption period; and
|
⯀
|
if, and only if, the reported closing price of our Class A common stock equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities — Warrants — Public Shareholders’ Warrants — Anti-dilution Adjustments”) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrantholders.
|
⯀
|
in whole and not in part;
|
⯀
|
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table set forth under “Description of Securities — Warrants — Public Stockholders’ Warrants” based on the redemption date and the “fair market value” (as defined below) of our Class A common stock except as otherwise described in “Description of Securities — Warrants — Public Stockholders’ Warrants”;
|
⯀
|
if, and only if, the closing price of our Class A common stock equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Description of Securities — Warrants — Public Stockholders’ Warrants — Anti-dilution Adjustments”) for any 20 trading days within the 30-trading day period ending three trading days before we send notice of redemption to the warrant holders; and
|
⯀
|
if the closing price of our Class A common stock for any 20 trading days within a 30-trading day period ending three trading days before we send notice of
|
⯀
|
the founder shares are shares of Class B common stock that automatically convert into shares of our Class A common stock at the time of our initial business combination on a one-for-one basis, subject to adjustment pursuant to certain anti-dilution rights as described herein;
|
⯀
|
the founder shares are subject to certain transfer restrictions, as described in more detail below;
|
⯀
|
the founder shares are entitled to registration rights;
|
⯀
|
our sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to (i) waive their redemption rights with respect to their founder shares and public shares in connection with the completion of our initial business combination, (ii) waive their redemption rights with respect to their founder shares and public shares in connection with a stockholder vote to approve an amendment to our amended and restated certificate of incorporation to (A) modify the substance or timing of our obligation to provide for the redemption of our public shares in connection with an initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of this offering or (B) with respect to any other material provisions relating to stockholders’ rights or pre-initial business combination activity, (iii) waive their rights to liquidating distributions from the trust account with respect to their founder shares if we fail to complete our initial business combination within 24 months from the closing of this offering, although they will be entitled to liquidating distributions from the trust account with respect to any public shares they hold if we fail to complete our initial business combination within the prescribed time frame and (iv) vote any founder shares held by them and any public shares purchased during or after this offering (including in open market and privately-negotiated transactions) in favor of our initial business combination.
|
⯀
|
the net proceeds of this offering and the sale of the private placement warrants not held in the trust account, which will be approximately $1,000,000 in working capital after the payment of approximately $1,000,000 in expenses relating to this offering; and
|
⯀
|
any loans or additional investments from our sponsor, or an affiliate of our sponsor or certain of our officers and directors, although they are under no obligation to advance funds or invest in us, and provided that any such loans will not have any claim on the proceeds held in the trust account unless such proceeds are released to us upon completion of our initial business combination. Up to $1,500,000 of such loans may be convertible into warrants, at a price of $1.50 per warrant at the option of the lender.
|
⯀
|
conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules, and
|
⯀
|
file proxy materials with the SEC.
|
⯀
|
conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers, and
|
⯀
|
file tender offer documents with the SEC prior to completing our initial business combination, which contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies.
|
⯀
|
Repayment of up to an aggregate of up to $300,000 in loans made to us by our sponsor to cover offering-related and organizational expenses;
|
⯀
|
Payment to an affiliate of our sponsor of $15,000 per month, for up to 24 months, for office space, utilities and secretarial and administrative support;
|
⯀
|
Reimbursement for any out-of-pocket expenses related to identifying, investigating, negotiating and completing an initial business combination; and
|
⯀
|
Repayment of loans which may be made by our sponsor or an affiliate of our sponsor or certain of our officers and directors to finance transaction costs in connection with an intended initial business combination, the terms of which have not been determined nor have any written agreements been executed with respect thereto. Up to $1,500,000 of such loans may be convertible into warrants, at a price of $1.50 per warrant at the option of the lender. The
|
Balance Sheet Data:
|
| |
January 22, 2021
(Audited)
|
Working capital (deficiency)
|
| |
$(26,000)
|
Total assets
|
| |
$75,000
|
Total liabilities
|
| |
$51,000
|
Stockholder’s equity
|
| |
$24,000
|
⯀
|
our being a company with no operating history and no revenues;
|
⯀
|
our ability to select an appropriate target business or businesses;
|
⯀
|
our ability to complete our initial business combination;
|
⯀
|
our expectations around the performance of a prospective target business or businesses;
|
⯀
|
our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination;
|
⯀
|
our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination;
|
⯀
|
our potential ability to obtain additional financing to complete our initial business combination;
|
⯀
|
our pool of prospective target businesses;
|
⯀
|
our ability to consummate an initial business combination due to the continued uncertainty resulting from the COVID-19 pandemic;
|
⯀
|
the ability of our officers and directors to generate a number of potential business combination opportunities;
|
⯀
|
our public securities’ potential liquidity and trading;
|
⯀
|
the lack of a market for our securities;
|
⯀
|
the use of proceeds not held in the trust account or available to us from interest income on the trust account balance;
|
⯀
|
the trust account not being subject to claims of third parties;
|
⯀
|
our financial performance following this offering; and
|
⯀
|
the other risks and uncertainties discussed in “Risk Factors” and elsewhere in this prospectus.
|
⯀
|
higher costs and difficulties inherent in managing cross-border business operations and complying with different commercial and legal requirements of overseas markets;
|
⯀
|
rules and regulations regarding currency redemption;
|
⯀
|
complex corporate withholding taxes on individuals;
|
⯀
|
laws governing the manner in which future business combinations may be effected;
|
⯀
|
tariffs and trade barriers;
|
⯀
|
regulations related to customs and import/export matters;
|
⯀
|
longer payment cycles and challenges in collecting accounts receivable;
|
⯀
|
tax issues, including, but not limited to, tax law changes and variations in tax laws as compared to the United States;
|
⯀
|
currency fluctuations and exchange controls;
|
⯀
|
rates of inflation;
|
⯀
|
cultural and language differences;
|
⯀
|
employment regulations;
|
⯀
|
changes in industry, regulatory or environmental standards within the jurisdictions where we operate;
|
⯀
|
crime, strikes, riots, civil disturbances, terrorist attacks, natural disasters and wars;
|
⯀
|
deterioration of political relations with the United States; and
|
⯀
|
government appropriations of assets.
|
⯀
|
default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations;
|
⯀
|
acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;
|
⯀
|
our immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;
|
⯀
|
our inability to obtain necessary additional financing if the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding;
|
⯀
|
our inability to pay dividends on our common stock;
|
⯀
|
using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our common stock if declared, our ability to pay expenses, make capital expenditures and acquisitions, and fund other general corporate purposes;
|
⯀
|
limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;
|
⯀
|
increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation;
|
⯀
|
limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, and execution of our strategy; and
|
⯀
|
other disadvantages compared to our competitors who have less debt.
|
⯀
|
solely dependent upon the performance of a single business, property or asset, or
|
⯀
|
dependent upon the development or market acceptance of a single or limited number of products, processes or services.
|
⯀
|
restrictions on the nature of our investments; and
|
⯀
|
restrictions on the issuance of securities, each of which may make it difficult for us to complete our initial business combination.
|
⯀
|
registration as an investment company;
|
⯀
|
adoption of a specific form of corporate structure; and
|
⯀
|
reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations.
|
⯀
|
a limited availability of market quotations for our securities;
|
⯀
|
reduced liquidity for our securities;
|
⯀
|
a determination that our Class A common stock is a “penny stock” which will require brokers trading in our Class A common stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities;
|
⯀
|
a limited amount of news and analyst coverage; and
|
⯀
|
a decreased ability to issue additional securities or obtain additional financing in the future.
|
⯀
|
may significantly dilute the equity interest of investors in this offering;
|
⯀
|
may subordinate the rights of holders of common stock if preferred stock is issued with rights senior to those afforded our common stock;
|
⯀
|
could cause a change of control if a substantial number of shares of our common stock are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; and
|
⯀
|
may adversely affect prevailing market prices for our units, Class A common stock and/or warrants.
|
(i)
|
we issue additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of our initial business combination at a Newly Issued Price of less than $9.20 per share;
|
(ii)
|
the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the consummation of our initial business combination (net of redemptions), and
|
(iii)
|
the Market Value is below $9.20 per share,
|
⯀
|
the history and prospects of companies whose principal business is the acquisition of other companies;
|
⯀
|
prior offerings of those companies;
|
⯀
|
our prospects for acquiring an operating business;
|
⯀
|
a review of debt to equity ratios in leveraged transactions;
|
⯀
|
our capital structure;
|
⯀
|
an assessment of our management and their experience in identifying operating companies;
|
⯀
|
general conditions of the securities markets at the time of this offering; and
|
⯀
|
other factors as were deemed relevant.
|
|
| |
Without Over-
Allotment Option
|
| |
Over-Allotment
Option Fully
Exercised
|
Gross proceeds
|
| |
|
| |
|
Gross proceeds from units offered to public(1)
|
| |
$200,000,000
|
| |
$230,000,000
|
Gross proceeds from private placement warrants offered in the private placement
|
| |
6,000,000
|
| |
6,600,000
|
Total gross proceeds
|
| |
$206,000,000
|
| |
$236,600,000
|
Offering expenses(2)
|
| |
|
| |
|
Underwriting commissions (2% of gross proceeds from units offered to public, excluding deferred portion)(3)
|
| |
$4,000,000
|
| |
$4,600,000
|
Legal fees and expenses
|
| |
225,000
|
| |
225,000
|
Accounting fees and expenses
|
| |
40,000
|
| |
40,000
|
SEC/FINRA Expenses
|
| |
60,093
|
| |
60,093
|
Travel and road show
|
| |
20,000
|
| |
20,000
|
Nasdaq listing and filing fees
|
| |
75,000
|
| |
75,000
|
Director and Officer liability insurance premiums
|
| |
375,000
|
| |
375,000
|
Printing and engraving expenses
|
| |
40,000
|
| |
40,000
|
Miscellaneous
|
| |
164,907
|
| |
164,907
|
Total offering expenses (excluding underwriting commissions)
|
| |
$1,000,000
|
| |
$1,000,000
|
Proceeds after offering expenses
|
| |
$201,000,000
|
| |
$231,000,000
|
Held in trust account(3)
|
| |
$200,000,000
|
| |
$230,000,000
|
% of public offering size
|
| |
100%
|
| |
100%
|
Not held in trust account
|
| |
$1,000,000
|
| |
$1,000,000
|
|
| |
Amount
|
| |
% of Total
|
Legal, accounting, due diligence, travel, and other expenses in connection with any business combination(5)
|
| |
$535,000
|
| |
53.5%
|
Legal and accounting fees related to regulatory reporting obligations
|
| |
100,000
|
| |
10.0%
|
Payment for office space, utilities and secretarial and administrative support
|
| |
180,000
|
| |
18.0%
|
Nasdaq continued listing fees
|
| |
75,000
|
| |
7.5%
|
Working capital to cover miscellaneous expenses (including taxes)
|
| |
110,000
|
| |
11.0%
|
Total
|
| |
$1,000,000
|
| |
100.0%
|
(1)
|
Includes amounts payable to public stockholders who properly redeem their shares in connection with our successful completion of our initial business combination. Includes gross proceeds from this offering of $200,000,000 (or $230,000,000 if the underwriters’ overallotment option is exercised in full).
|
(2)
|
A portion of the offering expenses will be paid from the proceeds of loans from our sponsor of up to an aggregate of $300,000 as described in this prospectus. As of January 22, 2021, we had no borrowings under the promissory note with our sponsor (of up to $300,000 available to us) to be used for a portion of the expenses of this offering. These amounts will be repaid upon completion of this offering out of the offering proceeds that has been allocated for the payment of offering expenses (other than underwriting commissions). In the event that offering expenses are more than as set forth in this table, they will be repaid using a portion of the $1,000,000 of offering proceeds not held in the trust account and set aside for post-closing working capital expenses. In the event that offering expenses are less than set forth in this table, any such amounts will be used for post-closing working capital expenses.
|
(3)
|
The underwriters have agreed to defer underwriting commissions equal to 3.5% of the gross proceeds of this offering. Upon completion of our initial business combination, $7,000,000, which constitutes the underwriter’s deferred commissions (or $8,050,000 if the underwriters’ over-allotment option is exercised in full) will be paid to the underwriters from the funds held in the trust account, and the remaining funds, less amounts released to the trustee to pay redeeming stockholders, will be released to us and can be used to pay all or a portion of the purchase price of the business or businesses with which our initial business combination occurs or for general corporate purposes, including payment of principal or interest on indebtedness incurred in connection with our initial business combination, to fund the purchases of other companies or for working capital. The underwriters will not be entitled to any interest accrued on the deferred underwriting discounts and commissions.
|
(4)
|
These expenses are estimates only and do not include interest which may be available to us from the trust account. Our actual expenditures for some or all of these items may differ from the estimates set forth herein. For example, we may incur greater legal and accounting expenses than our current estimates in connection with negotiating and structuring our initial business combination based upon the level of complexity of such business combination. In the event we identify an initial business combination target in a specific industry subject to specific regulations, we may incur additional expenses associated with legal due diligence and the engagement of special legal counsel. In addition, our staffing needs may vary and as a result, we may engage a number of consultants to assist with legal and financial due diligence. We do not anticipate any change in our intended use of proceeds, other than fluctuations among the current categories of allocated expenses, which fluctuations, to the extent they exceed current estimates for any specific category of expenses, would not be available for our expenses.
|
(5)
|
Includes estimated amounts that may also be used in connection with our initial business combination to fund a “no shop” provision and commitment fees for financing.
|
|
| |
No exercise of
over-allotment
option
|
| |
Exercise of
over-allotment
option in full
|
Public offering price
|
| |
$10.00
|
| |
$10.00
|
Net tangible book value before this offering
|
| |
$(0.00)
|
| |
$(0.00)
|
Increase attributable to public stockholders and sale of the private placement warrants
|
| |
$0.82
|
| |
$0.72
|
Pro forma net tangible book value after this offering
|
| |
$0.82
|
| |
$0.72
|
Dilution to public stockholders
|
| |
$9.18
|
| |
$9.28
|
Percentage of dilution to public stockholders
|
| |
91.8%
|
| |
92.8%
|
|
| |
Shares Purchased
|
| |
Total Consideration
|
| |
Average Price
Per Share
|
||||||
|
| |
Number
|
| |
Percentage
|
| |
Amount
|
| |
Percentage
|
| ||
Initial Stockholders(1)
|
| |
5,000,000
|
| |
20.000%
|
| |
$25,000
|
| |
0.01%
|
| |
$0.005
|
Public Stockholders
|
| |
20,000,000
|
| |
80.000%
|
| |
200,000,000
|
| |
99.99%
|
| |
$10.00
|
|
| |
25,000,000
|
| |
100.000%
|
| |
$200,025,000
|
| |
100.000%
|
| |
|
(1)
|
Assumes no exercise of the underwriters’ over-allotment option and the corresponding forfeiture of an aggregate of 750,000 shares of Class B common stock held by our sponsor and conversion of Class B common stock into Class A common stock on a one for-one basis. The dilution to public stockholders would increase to the extent that the anti-dilution provisions of the Class B common shares result in the issuance of Class A common shares on a greater than one-to-one basis upon such conversion.
|
|
| |
Without Over-
allotment
|
| |
With Over-
allotment
|
Numerator:
|
| |
|
| |
|
Net tangible book value before this offering
|
| |
$(26,000)
|
| |
$(26,000)
|
Plus: Offering costs paid in advance, excluded from tangible book value before this offering
|
| |
50,000
|
| |
50,000
|
Net proceeds from this offering and sale of the private placement warrants, net of expenses(1)
|
| |
201,000,000
|
| |
231,000,000
|
Less: Deferred underwriting commissions
|
| |
(7,000,000)
|
| |
(8,050,000)
|
Less: Proceeds held in trust subject to redemption to maintain net tangible assets of $5,000,001(2)
|
| |
(189,023,990)
|
| |
(217,973,990)
|
|
| |
$5,000,010
|
| |
$5,000,010
|
|
| |
|
| |
|
Denominator:
|
| |
|
| |
|
Shares of Class B common stock outstanding prior to this offering
|
| |
5,750,000
|
| |
5,750,000
|
Shares of Class B common stock forfeited if over-allotment is not exercised
|
| |
(750,000)
|
| |
—
|
Shares of Class A common stock included in the units offered
|
| |
20,000,000
|
| |
23,000,000
|
Less: Shares of Class A common stock subject to redemption
|
| |
(18,902,399)
|
| |
(21,797,399)
|
|
| |
6,097,601
|
| |
6,952,601
|
(1)
|
Expenses applied against gross proceeds include offering expenses of $1,000,000 and underwriting commissions of $4,000,000 (or $4,600,000 if the underwriters’ over-allotment option is exercised in full) (excluding deferred underwriting fees). See “Use of Proceeds.”
|
(2)
|
If we seek stockholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our sponsor, initial stockholders, directors, executive officers, advisors or their affiliates may purchase shares or public warrants’ in privately-negotiated transactions or in the open market, either prior to or following the completion of our initial business combination. In the event of any such purchases of our shares prior to the completion of our initial business combination, the number of shares of Class A common stock subject to redemption will be reduced by the amount of any such purchases, increasing the pro forma net tangible book value per share. See “Proposed Business — Effecting Our Initial Business Combination” and “Proposed Business — Permitted Purchases of Our Securities.”
|
|
| |
January 22, 2021
|
|||
|
| |
Actual
|
| |
As Adjusted(1)
|
Promissory note – related party
|
| |
$—
|
| |
$—
|
Deferred underwriting commissions
|
| |
—
|
| |
7,000,000
|
Class A common stock, $0.0001 par value, 100,000,000 shares authorized; -0- and 18,902,399 shares are subject to possible redemption, actual and as adjusted, respectively(2)(3)
|
| |
—
|
| |
189,023,990
|
Preferred stock, $0.0001 par value, 1,000,000 shares authorized; none issued and outstanding, actual and as adjusted
|
| |
—
|
| |
—
|
Class A common stock, $0.0001 par value, 100,000,000 shares authorized, -0- and 1,097,601 shares issued and outstanding (excluding -0- and 18,902,399 shares subject to redemption), actual and adjusted, respectively
|
| |
—
|
| |
110
|
Class B common stock, $0.0001 par value, 10,000,000 shares authorized, 5,750,000 and 5,000,000 shares issued and outstanding, actual and as adjusted, respectively(3)
|
| |
575
|
| |
500
|
Additional paid-in capital
|
| |
24,425
|
| |
5,000,400
|
Accumulated deficit
|
| |
(1,000)
|
| |
(1,000)
|
Total stockholders’ equity
|
| |
24,000
|
| |
5,000,010
|
Total capitalization
|
| |
$24,000
|
| |
$201,024,000
|
(1)
|
Our sponsor has agreed to loan us up to an aggregate of $300,000 to be used for a portion of the expenses of this offering. The “as adjusted” information gives effect to the repayment of any loans made under this note out of the proceeds from this offering and the sale of the private placement warrants. As of January 22, 2021, we had no borrowings under the promissory note with our sponsor to be used for a portion of the expenses of this offering.
|
(2)
|
Upon the completion of our initial business combination, we will provide our public stockholders with the opportunity to redeem their public shares for cash equal to their pro rata share of the aggregate amount then on deposit in the trust account as of two business days prior to the consummation of the initial business combination, including interest earned on the funds held in the trust account and not previously released to us to pay our taxes, subject to the limitations described herein whereby our net tangible assets will be maintained at a minimum of $5,000,001 either immediately prior to or upon consummation of our initial business combination and any limitations (including, but not limited to, cash requirements) created by the terms of the proposed initial business combination.
|
(3)
|
Actual share amount is prior to any forfeiture of founder shares by our sponsor and as adjusted amount assumes no exercise of the underwriters’ over-allotment option.
|
⯀
|
may significantly dilute the equity interest of investors in this offering, which dilution would increase if the anti-dilution provisions in the Class B common stock resulted in the issuance of Class A shares on a greater than one-to-one basis upon conversion of the Class B common stock;
|
⯀
|
may subordinate the rights of holders of our common stock if preferred stock is issued with rights senior to those afforded our common stock;
|
⯀
|
could cause a change in control if a substantial number of shares of our common stock is issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors;
|
⯀
|
may have the effect of delaying or preventing a change of control of us by diluting the stock ownership or voting rights of a person seeking to obtain control of us; and
|
⯀
|
may adversely affect prevailing market prices for our Class A common stock and/or warrants.
|
⯀
|
default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations;
|
⯀
|
acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;
|
⯀
|
our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand;
|
⯀
|
our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding;
|
⯀
|
our inability to pay dividends on our common stock;
|
⯀
|
using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our common stock if declared, our ability to pay expenses, make capital expenditures and acquisitions, and fund other general corporate purposes;
|
⯀
|
limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;
|
⯀
|
increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation;
|
⯀
|
limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, and execution of our strategy; and
|
⯀
|
other purposes and other disadvantages compared to our competitors who have less debt.
|
⯀
|
staffing for financial, accounting and external reporting areas, including segregation of duties;
|
⯀
|
reconciliation of accounts;
|
⯀
|
proper recording of expenses and liabilities in the period to which they relate;
|
⯀
|
evidence of internal review and approval of accounting transactions;
|
⯀
|
documentation of processes, assumptions and conclusions underlying significant estimates; and
|
⯀
|
documentation of accounting policies and procedures.
|
⯀
|
Operating companies, setting and changing strategies, and identifying, mentoring and recruiting exceptional talent;
|
⯀
|
Developing and growing companies, both organically and through strategic transactions and acquisitions, and expanding the product range and geographic footprint of a number of target businesses;
|
⯀
|
Investing in private and public technology companies to accelerate their growth and maturation;
|
⯀
|
Sourcing, structuring, acquiring, and selling businesses;
|
⯀
|
Accessing the capital markets; and
|
⯀
|
Fostering relationships with sellers, capital providers and target management teams.
|
⯀
|
Large and growing market. We will focus on investments in industry segments that we believe demonstrate attractive long-term growth prospects and reasonable overall size or potential;
|
⯀
|
Attractive, inherently profitable business with high operating leverage. We will seek to invest in companies that we believe possess not only established business models and sustainable competitive advantages, but also inherently profitable unit economics;
|
⯀
|
Strong management teams. We will spend significant time assessing a company’s leadership and personnel and evaluating what we can do to augment and/or upgrade the team over time if needed;
|
⯀
|
Opportunity for operational improvements. We will seek to identify businesses that we believe are stable but at an inflection point and would benefit from our ability to drive improvements in the company’s processes, go-to-market strategy, product or service offering, sales and marketing efforts, geographical presence and/or leadership team;
|
⯀
|
Differentiated products or services. We will evaluate metrics such as recurring revenues, product life cycle, cohort consistency, pricing per product or customer, cross-sell success and churn rates to focus on businesses whose products or services are differentiated or where we see an opportunity to create value by implementing best practices;
|
⯀
|
Compelling growth prospects. We view growth as an important driver of value and will seek companies whose growth potential can generate meaningful upside;
|
⯀
|
Limited technology risk. We will seek to invest in companies that have established market-tested product or service offerings;
|
⯀
|
Appropriate valuations. We will seek to be a disciplined and valuation-centric investor that will invest on terms that we believe provide significant upside potential with limited downside risk; and
|
⯀
|
Benefit from Being a Public Company. We intend to pursue a business combination with a company that we believe will benefit from being publicly traded and can effectively utilize the broader access to capital and public profile that are associated with being a publicly traded company.
|
⯀
|
Management team’s industry knowledge and contacts.
|
⯀
|
Deal flow and business development resources available to our sponsor and its affiliates.
|
⯀
|
Management team’s experience and reputation in sourcing opportunities.
|
⯀
|
Extensive relationships within the private equity community (a likely source of deal flow).
|
⯀
|
Management team’s demonstrated ability to create value for their shareholders.
|
⯀
|
Strong track record of operational excellence.
|
⯀
|
subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our initial business combination, and
|
⯀
|
cause us to depend on the marketing and sale of a single product or limited number of products or services.
|
Type of Transaction
|
| |
Whether
Stockholder
Approval is
Required
|
Purchase of assets
|
| |
No
|
Purchase of stock of target not involving a merger with the company
|
| |
No
|
Merger of target into a subsidiary of the company
|
| |
No
|
Merger of the company with a target
|
| |
Yes
|
⯀
|
we issue shares of Class A common stock that will be equal to or in excess of 20% of the number of shares of our Class A common stock then outstanding;
|
⯀
|
any of our directors, officers or substantial stockholders (as defined by Nasdaq rules) has a 5% or greater interest (or such persons collectively have a 10% or greater interest), directly or indirectly, in the target business or assets to be acquired or otherwise and the present or potential issuance of common stock could result in an increase in outstanding common shares or voting power of 5% or more; or
|
⯀
|
the issuance or potential issuance of common stock will result in our undergoing a change of control.
|
⯀
|
the timing of the transaction, including in the event we determine stockholder approval would require additional time and there is either not enough time to seek stockholder approval or doing so would place the company at a disadvantage in the transaction or result in other additional burdens on the company;
|
⯀
|
the expected cost of holding a stockholder vote;
|
⯀
|
the risk that the stockholders would fail to approve the proposed business combination;
|
⯀
|
other time and budget constraints of the company; and
|
⯀
|
additional legal complexities of a proposed business combination that would be time-consuming and burdensome to present to stockholders.
|
⯀
|
conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules, and
|
⯀
|
file proxy materials with the SEC.
|
⯀
|
conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers, and
|
⯀
|
file tender offer documents with the SEC prior to completing our initial business combination, which contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies.
|
|
| |
Redemptions In Connection
with Our Initial Business
Combination
|
| |
Other Permitted
Purchases of Public
Shares by us or our Affiliates
|
| |
Redemptions If we fail to
Complete an Initial Business
Combination
|
Calculation of redemption price
|
| |
Redemptions at the time of our initial business combination may be made pursuant to a tender offer or in connection with a stockholder vote. The same whether we conduct redemptions pursuant to a tender offer or in connection with a stockholder vote. In either case, our public stockholders may redeem their public shares for cash equal to the aggregate amount then on deposit in the trust account as of two business days prior to the consummation of the initial business combination (which is initially anticipated to be $10.00 per public share), including interest earned on the funds held in the trust account and not previously released to us to pay our taxes divided by the number of then outstanding public shares, subject to the limitation that no redemptions will take place, if all of the redemptions would cause our net tangible assets will be at least $5,000,001 either immediately prior to or upon consummation of our initial business combination and any limitations (including, but not limited to, cash requirements) agreed to in connection with the negotiation of
|
| |
If we seek stockholder approval of our initial business combination, our sponsor, directors, officers, advisors or their affiliates may purchase shares in privately-negotiated transactions or in the open market prior to or following completion of our initial business combination. There is no limit to the prices that our sponsor, directors, officers, advisors or their affiliates may pay in these transactions. Such purchases will be made only to the extent such purchases are able to be made in compliance with Rule 10b-18, which is a safe harbor from liability for manipulation under Section 9(a)(2) and Rule 10b-5 of the Exchange Act. None of the funds in the trust account will be used to purchase shares in such transactions.
|
| |
If we are unable to complete our initial business combination within 24 months from the closing of this offering, we will redeem 100% of the public shares at a per-share price, payable in cash, equal to the aggregate amount, then on deposit in the trust account (which is initially anticipated to be $10.00 per public share including, interest earned on the funds held in the trust account and not previously released to us to pay our taxes (less up to $100,000 of interest to pay dissolution expenses)), divided by the number of then outstanding public shares.
|
|
| |
Redemptions In Connection
with Our Initial Business
Combination
|
| |
Other Permitted
Purchases of Public
Shares by us or our Affiliates
|
| |
Redemptions If we fail to
Complete an Initial Business
Combination
|
|
| |
terms of a proposed initial business combination.
|
| |
|
| |
|
|
| |
|
| |||||
Impact to remaining stockholders
|
| |
The redemptions in connection with our initial business combination will reduce the book value per share for our remaining stockholders, who will bear the burden of the deferred underwriting commissions and taxes payable.
|
| |
If the permitted purchases described above are made there would be no impact to our remaining stockholders because the purchase price would not be paid by us.
|
| |
The redemption of our public shares if we fail to complete our initial business combination will reduce the book value per share for the shares held by our initial stockholders, who will be our only remaining stockholders after such redemptions.
|
|
| |
Terms of our Offering
|
| |
Terms under a Rule 419 Offering
|
Escrow of offering proceeds
|
| |
$200,000,000 of the net proceeds of this offering and the sale of the private placement warrants will be deposited into a trust account in the United States at J.P. Morgan Chase Bank, N.A., with Continental Stock Transfer & Trust Company acting as trustee.
|
| |
Approximately $170,100,000 of the offering proceeds would be deposited into either an escrow account with an insured depositary institution or in a separate bank account established by a broker-dealer in which the broker-dealer acts as trustee for persons having the beneficial interests in the account.
|
|
| |
|
| ||
Investment of net proceeds
|
| |
$200,000,000 of the net offering proceeds and the sale of the private placement warrants held in trust will be invested only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations.
|
| |
Proceeds could be invested only in specified securities such as a money market fund meeting conditions of the Investment Company Act or in securities that are direct obligations of, or obligations guaranteed as to principal or interest by, the United States.
|
|
| |
Terms of our Offering
|
| |
Terms under a Rule 419 Offering
|
Receipt of interest on escrowed funds
|
| |
Interest on proceeds from the trust account to be paid to redeeming stockholders is reduced by (i) any taxes paid or payable, and (ii) in the event of our liquidation for failure to complete our initial business combination within the allotted time, up to $100,000 of net interest that may be released to us should we have no or insufficient working capital to fund the costs and expenses of our dissolution and liquidation.
|
| |
Interest on funds in escrow account would be held for the sole benefit of investors, unless and only after the funds held in escrow were released to us in connection with our completion of a business combination.
|
|
| |
|
| ||
Limitation on fair value or net assets of target business
|
| |
Nasdaq rules require that we must consummate an initial business combination with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the trust account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting commissions).
|
| |
The fair value or net assets of a target business must represent at least 80% of the maximum offering proceeds.
|
|
| |
|
| ||
Trading of securities issued
|
| |
We expect the units will begin trading on or promptly after the date of this prospectus. The Class A common stock and warrants comprising the units will begin separate trading on the 52nd day following the date of this prospectus unless Jefferies LLC informs us of its decision to allow earlier separate trading, subject to our having filed the Current Report on Form 8-K described below and having issued a press release announcing when such separate trading will begin. We will file the Current Report on Form 8-K promptly after the closing of this offering, which closing is anticipated to take place three business days from the date of this prospectus. If the over-allotment option is exercised following the initial filing of such Current Report on Form 8-K, an additional Current Report on Form 8-K will be filed to provide updated financial information to reflect the exercise of the over-allotment option.
|
| |
No trading of the units or the underlying Class A common stock and warrants would be permitted until the completion of a business combination. During this period, the securities would be held in the escrow or trust account.
|
|
| |
|
|
|
| |
Terms of our Offering
|
| |
Terms under a Rule 419 Offering
|
Exercise of the warrants
|
| |
The warrants cannot be exercised until 30 days after the completion of our initial business combination.
|
| |
The warrants could be exercised prior to the completion of a business combination, but securities received and cash paid in connection with the exercise would be deposited in the escrow or trust account.
|
|
| |
|
| |
|
Election to remain an investor
|
| |
We will provide our public stockholders with the opportunity to redeem their public shares for cash equal to their pro rata share of the aggregate amount then on deposit in the trust account as of two business days prior to the consummation of our initial business combination, including interest earned on the funds held in the trust account and not previously released to us to pay our taxes, upon the completion of our initial business combination, subject to the limitations described herein. We may not be required by law to hold a stockholder vote.
We intend to give approximately 30 days’ (but not less than 10 days’ nor more than 60 days’) prior written notice of any such meeting, if required, at which a vote shall be taken to approve our initial business combination. If we are not required by law and do not otherwise decide to hold a stockholder vote, we will, pursuant to our amended and restated certificate of incorporation, conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC which will contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under the SEC’s proxy rules. In the event we conduct redemptions pursuant to the tender offer rules, our offer to redeem will remain open for at least 20 business days, in accordance with Rule 14e-1(a) under the Exchange Act, and we will not be permitted to complete our initial business combination until the expiration of the tender offer period.
|
| |
A prospectus containing information pertaining to the business combination required by the SEC would be sent to each investor. Each investor would be given the opportunity to notify the company in writing, within a period of no less than 20 business days and no more than 45 business days from the effective date of a post-effective amendment to the company’s registration statement, to decide if it elects to remain a stockholder of the company or require the return of its investment. If the company has not received the notification by the end of the 45th business day, funds and interest or dividends, if any, held in the trust or escrow account are automatically returned to the stockholder. Unless a sufficient number of investors elect to remain investors, all funds on deposit in the escrow account must be returned to all of the investors and none of the securities are issued.
|
|
| |
Terms of our Offering
|
| |
Terms under a Rule 419 Offering
|
|
| |
subject to the approval of our remaining stockholders and our board of directors, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.
|
| |
|
|
| |
|
| |
|
Limitation on redemption rights of stockholders holding more than 15% of the shares sold in this offering if we hold a stockholder vote
|
| |
If we seek stockholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our amended and restated certificate of incorporation will provide that a public stockholder (including our affiliates), together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Exchange Act), will be restricted from seeking redemption rights with respect to Excess Shares (more than an aggregate of 15% of the shares sold in this offering). Our public stockholders’ inability to redeem Excess Shares will reduce their influence over our ability to complete our initial business combination and they could suffer a material loss on their investment in us if they sell any Excess Shares in open market transactions.
|
| |
Many blank check companies provide no restrictions on the ability of stockholders to redeem shares based on the number of shares held by such stockholders in connection with an initial business combination.
|
|
| |
|
| |
|
Tendering stock certificates in connection with a tender offer or redemption rights
|
| |
We intend to require our public stockholders seeking to exercise their redemption rights, whether they are record holders or hold their shares in “street name,” to, at the holder’s option, either deliver their stock certificates to our transfer agent or deliver their shares to our transfer agent electronically using the Depository Trust Company’s DWAC (Deposit/Withdrawal At Custodian) system, prior to the date set forth in the proxy materials or tender offer documents, as applicable. In the case of proxy materials, this date may be up to two business days prior to the vote on the proposal to approve the
|
| |
In order to perfect redemption rights in connection with their business combinations, holders could vote against a proposed initial business combination and check a box on the proxy card indicating such holders were seeking to exercise their redemption rights. After the business combination was approved, the Company would contact such stockholders to arrange for them to deliver their certificate to verify ownership.
|
|
| |
Terms of our Offering
|
| |
Terms under a Rule 419 Offering
|
|
| |
other material provisions relating to stockholders’ rights or pre-initial business combination activity, and (iii) the redemption of 100% of our public shares if we are unable to complete an initial business combination within the required time frame (subject to the requirements of applicable law). On the completion of our initial business combination, all amounts held in the trust account will be released to us, less amounts released to a separate account controlled by the trustee for disbursal to redeeming stockholders. We will use these funds to pay amounts due to any public stockholders who exercise their redemption rights as described above under “Redemption rights for public stockholders upon completion of our initial business combination,” to pay the underwriters their deferred underwriting commissions, to pay all or a portion of the consideration payable to the target or owners of the target of our initial business combination and to pay other expenses associated with our initial business combination.
|
| |
|
Name
|
| |
Age
|
| |
Position
|
Jonathan S. Huberman
|
| |
55
|
| |
Chairman, Chief Executive Officer and Chief Financial Officer
|
Mike Nikzad
|
| |
56
|
| |
Vice President of Acquisitions and Director Nominee
|
Andrew K. Nikou
|
| |
43
|
| |
Director Nominee
|
C. Matthew Olton
|
| |
54
|
| |
Director Nominee
|
Stephanie Davis
|
| |
57
|
| |
Director Nominee
|
Steven Guggenheimer
|
| |
55
|
| |
Director Nominee
|
Dr. Peter H. Diamandis
|
| |
59
|
| |
Director Nominee
|
⯀
|
the appointment, compensation, retention, replacement, and oversight of the work of the independent registered public accounting firm engaged by us;
|
⯀
|
pre-approving all audit and permitted non-audit services to be provided by the independent registered public accounting firm engaged by us, and establishing pre-approval policies and procedures;
|
⯀
|
setting clear hiring policies for employees or former employees of the independent registered public accounting firm, including but not limited to, as required by applicable laws and regulations;
|
⯀
|
setting clear policies for audit partner rotation in compliance with applicable laws and regulations;
|
⯀
|
obtaining and reviewing a report, at least annually, from the independent registered public accounting firm describing (i) the independent registered public accounting firm’s internal quality-control procedures, (ii) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues and (iii) all relationships between the independent registered public accounting firm and us to assess the independent registered public accounting firm’s independence;
|
⯀
|
reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and
|
⯀
|
reviewing with management, the independent registered public accounting firm, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities.
|
⯀
|
reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, if any is paid by us, evaluating our Chief Executive Officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation;
|
⯀
|
reviewing and approving on an annual basis the compensation, if any is paid by us, of all of our other officers;
|
⯀
|
reviewing on an annual basis our executive compensation policies and plans;
|
⯀
|
implementing and administering our incentive compensation equity-based remuneration plans;
|
⯀
|
assisting management in complying with our proxy statement and annual report disclosure requirements;
|
⯀
|
approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers and employees;
|
⯀
|
if required, producing a report on executive compensation to be included in our annual proxy statement; and
|
⯀
|
reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors.
|
⯀
|
None of our officers or directors is required to commit his or her full time to our affairs and, accordingly, may have conflicts of interest in allocating his or her time among various business activities.
|
⯀
|
In the course of their other business activities, our officers and directors may become aware of investment and business opportunities which may be appropriate for presentation to us, as well as the other entities with which they are affiliated. Our management may have conflicts of interest in determining to which entity a particular business opportunity should be presented.
|
⯀
|
Our initial stockholders have agreed to waive their redemption rights with respect to any founder shares and any public shares held by them in connection with the consummation of our initial business combination. Additionally, our initial stockholders have agreed to waive their redemption rights with respect to any founder shares held by them if we fail to consummate our initial business combination within 24 months after the closing of this offering. If we do not complete our initial business combination within such applicable time period, the proceeds of the sale of the private placement warrants held in the trust account will be used to fund the redemption of our public shares, and the private placement warrants will expire worthless. With certain limited exceptions, the founder shares will not be transferable, assignable by our sponsor until the earlier of: (A) one year after the completion of our initial business combination or (B) subsequent to our initial business combination, (x) if the reported closing price of our Class A common stock equals or exceeds $12.00 per share (as adjusted for
|
⯀
|
Our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to our initial business combination.
|
⯀
|
Our sponsor, officers or directors may have a conflict of interest with respect to evaluating a business combination and financing arrangements as we may obtain loans from our sponsor or an affiliate of our sponsor or any of our officers or directors to finance transaction costs in connection with an intended initial business combination. Up to $1,500,000 of such loans may be convertible into warrants at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the private placement warrants, including as to exercise price, exercisability and exercise period.
|
⯀
|
the corporation could financially undertake the opportunity;
|
⯀
|
the opportunity is within the corporation’s line of business; and
|
⯀
|
it would not be fair to our company and its stockholders for the opportunity not to be brought to the attention of the corporation.
|
Individual
|
| |
Entity
|
| |
Entity’s Business
|
| |
Affiliation
|
Jonathan Huberman
|
| |
Aculon, Inc.
|
| |
Nanotechnology
|
| |
Director
|
|
| |
Venture Corporation
|
| |
Design and Manufacturing
|
| |
Director
|
|
| |
CuriosityStream
|
| |
Streaming Media
|
| |
Officer and Director
|
|
| |
Software Acquisition Group Inc. II
|
| |
Blank Check
|
| |
Officer and Director
|
Mike Nikzad
|
| |
CuriosityStream
|
| |
Streaming Media
|
| |
Officer and Director
|
|
| |
Software Acquisition Group Inc. II
|
| |
Blank Check
|
| |
Officer and Director
|
|
| |
|
| |
|
| |
|
Andrew K. Nikou(1)
|
| |
OpenGate Capital Management, LLC
|
| |
Investing
|
| |
Principal
|
|
| |
Software Acquisition Group Inc. II
|
| |
Blank Check
|
| |
Director
|
|
| |
|
| |
|
| |
|
C. Matthew Olton
|
| |
Tenable Holdings
|
| |
Exposure Protection
|
| |
Officer
|
|
| |
Software Acquisition Group Inc. II
|
| |
Blank Check
|
| |
Director
|
|
| |
|
| |
|
| |
|
Stephanie Davis
|
| |
Korn/Ferry
|
| |
Consulting
|
| |
Partner
|
|
| |
Athenex
|
| |
Biopharmaceuticals
|
| |
Director
|
|
| |
Software Acquisition Group Inc. II
|
| |
Blank Check
|
| |
Director
|
|
| |
|
| |
|
| |
|
Steven Guggenheimer
|
| |
HSBC Holdings plc
|
| |
Banking
|
| |
Director
|
|
| |
Forrit Technology Ltd
|
| |
Cloud Technology
|
| |
Director
|
|
| |
Software Acquisition Group Inc. II
|
| |
Blank Check
|
| |
Director
|
|
| |
BOLD Capital Partners
|
| |
Venture Capital
|
| |
Principal
|
|
| |
|
| |
|
| |
|
Peter H. Diamandis(2)
|
| |
PHD Ventures, Inc.
|
| |
Personal Holding Co.
|
| |
Officer
|
|
| |
Fountain Therapeutic Services Inc.
|
| |
Regenerative Medicine
|
| |
Director
|
|
| |
Covaxx, Inc.
|
| |
Pharmaceuticals
|
| |
Director
|
|
| |
Celularity
|
| |
Therapeutics
|
| |
Director
|
|
| |
Space Adventures
|
| |
Space Tourism
|
| |
Managing Director
|
|
| |
Software Acquisition Group Inc. II
|
| |
Blank Check
|
| |
Director
|
(1)
|
Mr. Nikou is also a director of portfolio companies of private equity funds advised by OpenGate, and may be obligated to show acquisitions to such private equity funds and/or such portfolio companies before we may pursue such acquisitions
|
(2)
|
Dr. Diamandis is also a director of portfolio companies of BOLD Capital Partners, and may be obligated to show acquisitions to such companies before we may pursue such acquisitions.
|
⯀
|
each person known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock;
|
⯀
|
each of our executive officers, directors and director nominees; and
|
⯀
|
all our executive officers, directors and director nominees as a group.
|
|
| |
Before Offering
|
| |
After Offering
|
||||||
Name and Address of Beneficial Owner(1)
|
| |
Number
of Shares
Beneficially
Owned(2)
|
| |
Approximate
Percentage of
Outstanding
Common Stock
|
| |
Number
of Shares
Beneficially
Owned(2)
|
| |
Approximate
Percentage of
Outstanding
Common Stock
|
Software Acquisition Holdings III LLC(3)
|
| |
5,750,000
|
| |
100.0%
|
| |
5,000,000
|
| |
20.0%
|
Jonathan Huberman(4)
|
| |
5,750,000
|
| |
100.0%
|
| |
5,000,000
|
| |
20.0%
|
Mike Nikzad(4)
|
| |
5,750,000
|
| |
100.0%
|
| |
5,000,000
|
| |
20.0%
|
Andrew K. Nikou(4)
|
| |
5,750,000
|
| |
100.0%
|
| |
5,000,000
|
| |
20.0%
|
C. Matthew Olton(4)
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Stephanie Davis(4)
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Steven Guggenheimer(4)
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
Dr. Peter H. Diamandis(4)
|
| |
—
|
| |
—
|
| |
—
|
| |
—
|
All executive officers, directors and director nominees as a group (7 individuals)
|
| |
5,750,000
|
| |
100.0%
|
| |
5,000,000
|
| |
20.0%
|
*
|
less than 1%
|
(1)
|
Unless otherwise noted, the business address of each of the following entities or individuals is c/o Software Acquisition Group Inc. III, 1980 Festival Plaza Drive, Ste. 300, Las Vegas, Nevada 89135.
|
(2)
|
Interests shown consist solely of founder shares, classified as shares of Class B common stock. Such shares are convertible into shares of Class A common stock on a one-for-one basis, subject to adjustment, as described in the section of this prospectus entitled “Description of Securities.”
|
(3)
|
Our sponsor is the record holder of such shares. Our sponsor is controlled by a board of managers which consists of Jonathan Huberman, our Chairman, Chief Executive Officer and Chief Financial Officer, Mike Nikzad, our Vice President of Acquisitions and a director nominee, and Andrew Nikou, one of our director nominees. As such, they have voting and investment discretion with respect to the common stock held of record by our sponsor and may be deemed to have shared beneficial ownership of the common stock held directly by our sponsor.
|
(4)
|
Each of these individuals holds a direct or indirect interest in our sponsor. Each such person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly.
|
⯀
|
20,000,000 shares of our Class A common stock underlying the units being offered in this offering; and
|
⯀
|
5,000,000 shares of Class B common stock held by our initial stockholders.
|
⯀
|
in whole and not in part;
|
⯀
|
at a price of $0.01 per warrant;
|
⯀
|
upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrantholder; and
|
⯀
|
if, and only if, the reported closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three business days before we send the notice of redemption to the warrantholders.
|
⯀
|
in whole and not in part;
|
⯀
|
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the “fair market value” (as defined below) of our Class A common stock except as otherwise described below;
|
⯀
|
if, and only if, the closing price of our Class A common stock equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “— Warrants — Public Stockholders’ Warrants — Anti-Dilution Adjustments”) for any 20 trading days within the 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders; and
|
⯀
|
if the closing price of our Class A common stock for any 20 trading days within a 30-trading day period ending three trading days before we send notice of redemption to the warrant holders is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “— Warrants — Public Shareholders’ Warrants — Anti-dilution Adjustments”), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above.
|
Redemption Date (period to expiration of warrants)
|
| |
Fair Market Value of Class A Ordinary Shares
|
||||||||||||||||||||||||
|
≤ $10.00
|
| |
11.00
|
| |
12.00
|
| |
13.00
|
| |
14.00
|
| |
15.00
|
| |
16.00
|
| |
17.00
|
| |
≥ 18.00
|
||
60 months
|
| |
0.261
|
| |
0.281
|
| |
0.297
|
| |
0.311
|
| |
0.324
|
| |
0.337
|
| |
0.348
|
| |
0.358
|
| |
0.361
|
57 months
|
| |
0.257
|
| |
0.277
|
| |
0.294
|
| |
0.310
|
| |
0.324
|
| |
0.337
|
| |
0.348
|
| |
0.358
|
| |
0.361
|
54 months
|
| |
0.252
|
| |
0.272
|
| |
0.291
|
| |
0.307
|
| |
0.322
|
| |
0.335
|
| |
0.347
|
| |
0.357
|
| |
0.361
|
51 months
|
| |
0.246
|
| |
0.268
|
| |
0.287
|
| |
0.304
|
| |
0.320
|
| |
0.333
|
| |
0.346
|
| |
0.357
|
| |
0.361
|
48 months
|
| |
0.241
|
| |
0.263
|
| |
0.283
|
| |
0.301
|
| |
0.317
|
| |
0.332
|
| |
0.344
|
| |
0.356
|
| |
0.361
|
45 months
|
| |
0.235
|
| |
0.258
|
| |
0.279
|
| |
0.298
|
| |
0.315
|
| |
0.330
|
| |
0.343
|
| |
0.356
|
| |
0.361
|
42 months
|
| |
0.228
|
| |
0.252
|
| |
0.274
|
| |
0.294
|
| |
0.312
|
| |
0.328
|
| |
0.342
|
| |
0.355
|
| |
0.361
|
39 months
|
| |
0.221
|
| |
0.246
|
| |
0.269
|
| |
0.290
|
| |
0.309
|
| |
0.325
|
| |
0.340
|
| |
0.354
|
| |
0.361
|
36 months
|
| |
0.213
|
| |
0.239
|
| |
0.263
|
| |
0.285
|
| |
0.305
|
| |
0.323
|
| |
0.339
|
| |
0.353
|
| |
0.361
|
33 months
|
| |
0.205
|
| |
0.232
|
| |
0.257
|
| |
0.280
|
| |
0.301
|
| |
0.320
|
| |
0.337
|
| |
0.352
|
| |
0.361
|
30 months
|
| |
0.196
|
| |
0.224
|
| |
0.250
|
| |
0.274
|
| |
0.297
|
| |
0.316
|
| |
0.335
|
| |
0.351
|
| |
0.361
|
27 months
|
| |
0.185
|
| |
0.214
|
| |
0.242
|
| |
0.268
|
| |
0.291
|
| |
0.313
|
| |
0.332
|
| |
0.350
|
| |
0.361
|
24 months
|
| |
0.173
|
| |
0.204
|
| |
0.233
|
| |
0.260
|
| |
0.285
|
| |
0.308
|
| |
0.329
|
| |
0.348
|
| |
0.361
|
21 months
|
| |
0.161
|
| |
0.193
|
| |
0.223
|
| |
0.252
|
| |
0.279
|
| |
0.304
|
| |
0.326
|
| |
0.347
|
| |
0.361
|
18 months
|
| |
0.146
|
| |
0.179
|
| |
0.211
|
| |
0.242
|
| |
0.271
|
| |
0.298
|
| |
0.322
|
| |
0.345
|
| |
0.361
|
15 months
|
| |
0.130
|
| |
0.164
|
| |
0.197
|
| |
0.230
|
| |
0.262
|
| |
0.291
|
| |
0.317
|
| |
0.342
|
| |
0.361
|
12 months
|
| |
0.111
|
| |
0.146
|
| |
0.181
|
| |
0.216
|
| |
0.250
|
| |
0.282
|
| |
0.312
|
| |
0.339
|
| |
0.361
|
9 months
|
| |
0.090
|
| |
0.125
|
| |
0.162
|
| |
0.199
|
| |
0.237
|
| |
0.272
|
| |
0.305
|
| |
0.336
|
| |
0.361
|
6 months
|
| |
0.065
|
| |
0.099
|
| |
0.137
|
| |
0.178
|
| |
0.219
|
| |
0.259
|
| |
0.296
|
| |
0.331
|
| |
0.361
|
3 months
|
| |
0.034
|
| |
0.065
|
| |
0.104
|
| |
0.150
|
| |
0.197
|
| |
0.243
|
| |
0.286
|
| |
0.326
|
| |
0.361
|
0 months
|
| |
—
|
| |
—
|
| |
0.042
|
| |
0.115
|
| |
0.179
|
| |
0.233
|
| |
0.281
|
| |
0.323
|
| |
0.361
|
⯀
|
if we are unable to complete our initial business combination within 24 months from the closing of this offering, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than 10 business days thereafter subject to lawfully available funds therefor, redeem 100% of the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to us to pay our taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors, liquidate and dissolve, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law;
|
⯀
|
prior to our initial business combination, we may not issue additional shares of capital stock that would entitle the holders thereof to (i) receive funds from the trust account, (ii) vote on any initial business combination or (iii) vote on matters related to our pre-initial business combination activity;
|
⯀
|
although we do not intend to enter into an initial business combination with a target business that is affiliated with our sponsor, our directors or our officers, we are not prohibited from doing so. In the event we enter into such a transaction, we, or a committee of independent directors, will obtain an opinion from an independent investment banking firm or another independent entity that commonly renders valuation opinions, that such an initial business combination is fair to our company from a financial point of view;
|
⯀
|
if a stockholder vote on our initial business combination is not required by law and we do not decide to hold a stockholder vote for business or other legal reasons, we will offer to redeem our public shares pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, and will file tender offer documents with the SEC prior to completing our initial business combination, which contain substantially the same financial and other information about our initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act; whether or not we maintain our registration under the our Exchange Act or our listing on the Nasdaq, we will provide our public stockholders with the opportunity to redeem their public shares by one of the two methods listed above;
|
⯀
|
so long as we obtain and maintain a listing for our securities on the Nasdaq, the Nasdaq requires that we must consummate an initial business combination with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the trust account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting commissions);
|
⯀
|
if our stockholders approve an amendment to our amended and restated certificate of incorporation to (A) modify the substance or timing of our obligation to provide for the redemption of our public shares in connection with an initial business combination or to redeem 100% of our public shares if we do not complete our initial business
|
⯀
|
we will not effectuate our initial business combination with another blank check company or a similar company with nominal operations.
|
⯀
|
a stockholder who owns 15% or more of our outstanding voting stock (otherwise known as an “interested stockholder”);
|
⯀
|
an affiliate of an interested stockholder; or
|
⯀
|
an associate of an interested stockholder, for three years following the date that the stockholder became an interested stockholder.
|
⯀
|
our board of directors approves the transaction that made the stockholder an “interested stockholder,” prior to the date of the transaction;
|
⯀
|
after the completion of the transaction that resulted in the stockholder becoming an interested stockholder, that stockholder owned at least 85% of our voting stock outstanding at the time the transaction commenced, other than statutorily excluded shares of common stock; or
|
⯀
|
on or subsequent to the date of the transaction, the initial business combination is approved by our board of directors and authorized at a meeting of our stockholders, and not by written consent, by an affirmative vote of at least two-thirds of the outstanding voting stock not owned by the interested stockholder.
|
⯀
|
1% of the total number of shares of Class A common stock then outstanding, which will equal 200,000 shares immediately after this offering (or 230,000 if the underwriters exercise their over-allotment option in full); or
|
⯀
|
the average weekly reported trading volume of the Class A common stock during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale.
|
⯀
|
the issuer of the securities that was formerly a shell company has ceased to be a shell company;
|
⯀
|
the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act;
|
⯀
|
the issuer of the securities has filed all Exchange Act reports and materials required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Current Reports on Form 8-K; and
|
⯀
|
at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company.
|
⯀
|
our founders or initial stockholders;
|
⯀
|
banks, financial institutions or financial services entities;
|
⯀
|
broker-dealers;
|
⯀
|
governments or agencies or instrumentalities thereof;
|
⯀
|
regulated investment companies;
|
⯀
|
real estate investment trusts;
|
⯀
|
expatriates or former long-term residents of the United States;
|
⯀
|
insurance companies;
|
⯀
|
dealers or traders subject to a mark-to-market method of accounting with respect to the securities;
|
⯀
|
persons holding the securities as part of a “straddle,” hedge, integrated investment or similar transaction;
|
⯀
|
U.S. holders (as defined below) whose functional currency is not the U.S. dollar;
|
⯀
|
persons that acquired our securities through the exercise of employee stock options or otherwise as compensation through a tax-qualified retirement plan;
|
⯀
|
persons who actually or constructively own five percent or more (by vote or value) of our stock;
|
⯀
|
partnerships or other pass-through entities or arrangements for U.S. federal income tax purposes and any beneficial owners of such entities or arrangements; and
|
⯀
|
tax-exempt entities.
|
⯀
|
an individual who is a citizen or resident of the United States;
|
⯀
|
a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) organized in or under the laws of the United States, any state thereof or the District of Columbia;
|
⯀
|
an estate the income of which is includible in gross income for U.S. federal income tax purposes regardless of its source;
|
⯀
|
or a trust, if (i) a court within the United States is able to exercise primary supervision over the administration of the trust and one or more United States persons (as defined in the Code) have authority to control all substantial decisions of the trust or (ii) it has a valid election in effect under Treasury Regulations to be treated as a United States person.
|
⯀
|
a non-resident alien individual (other than certain former citizens and residents of the United States subject to U.S. tax as expatriates);
|
⯀
|
a foreign corporation; or
|
⯀
|
an estate or trust that is not a U.S. holder;
|
⯀
|
the Non-U.S. holder is an individual who is present in the United States for a period or periods aggregating 183 days or more during the calendar year in which the sale or disposition occurs and certain other conditions are met;
|
⯀
|
the gain is effectively connected with the conduct of a trade or business by the Non-U.S. holder within the United States (and, under an applicable income tax treaty, is attributable to a permanent establishment or fixed base maintained in the United States by the Non-U.S. holder); or
|
⯀
|
we are or have been a “U.S. real property holding corporation” for U.S. federal income tax purposes (a “USRPHC”) at any time during the shorter of the five-year period ending on the date of disposition or the Non-U.S. holder’s holding period for the applicable security (the “relevant period”).
|
Underwriter
|
| |
Number of Units
|
Jefferies LLC
|
| |
|
Total
|
| |
20,000,000
|
|
| |
Per Unit(1)
|
| |
Total(1)
|
||||||
|
| |
Without
Over-allotment
|
| |
With
Over-allotment
|
| |
Without
Over-allotment
|
| |
With
Over-allotment
|
Underwriting Discounts and Commissions paid by us
|
| |
$0.55
|
| |
$0.55
|
| |
$11,000,00
|
| |
$12,650,000
|
(1)
|
Includes $0.35 per unit, or $7,000,000 in the aggregate payable to the underwriters (or $8,050,000 if the over-allotment option is exercised in full) will be deposited in the trust account as deferred underwriting commissions. The deferred commissions will be released to the underwriters only on and concurrently with completion of an initial business combination.
|
⯀
|
the purchaser is entitled under applicable provincial securities laws to purchase the securities without the benefit of a prospectus qualified under those securities laws as it is an “accredited investor” as defined under National Instrument 45-106 — Prospectus Exemptions;
|
⯀
|
the purchaser is a “permitted client” as defined in National Instrument 31-103 — Registration Requirements, Exemptions and Ongoing Registrant Obligations;
|
⯀
|
where required by law, the purchaser is purchasing as principal and not as agent; and
|
⯀
|
the purchaser has reviewed the text above under Resale Restrictions.
|
⯀
|
a “sophisticated investor” under section 708(8)(a) or (b) of the Corporations Act;
|
⯀
|
a “sophisticated investor” under section 708(8)(c) or (d) of the Corporations Act and that you have provided an accountant’s certificate to the Company which complies with the requirements of section 708(8)(c)(i) or (ii) of the Corporations Act and related regulations before the offer has been made;
|
⯀
|
a person associated with the Company under Section 708(12) of the Corporations Act; or
|
⯀
|
a “professional investor” within the meaning of section 708(11)(a) or (b) of the Corporations Act.
|
(a)
|
to any legal entity which is a qualified investor as defined under Article 2 of the Prospectus Regulation;
|
(b)
|
to fewer than 150 natural or legal persons (other than qualified investors as defined under the Article 2 of the Prospectus Regulation), subject to obtaining the prior consent of representatives for any such offer; or
|
(c)
|
in any other circumstances falling within Article 1(4) of the Prospectus Regulation,
|
⯀
|
a corporation (which is not an accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or
|
⯀
|
a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor, securities (as defined in Section 239(1) of the SFA) of that corporation or the beneficiaries’ rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the securities pursuant to an offer made under Section 275 of the SFA except:
|
⯀
|
to an institutional investor or to a relevant person defined in Section 275(2) of the SFA, or to any person arising from an offer referred to in Section 275(1A) or Section 276(4)(i)(B) of the SFA;
|
⯀
|
where no consideration is or will be given for the transfer;
|
⯀
|
where the transfer is by operation of law;
|
⯀
|
as specified in Section 276(7) of the SFA; or
|
⯀
|
as specified in Regulation 32 of the Securities and Futures (Offers of Investments) (Shares and Debentures) Regulations 2005 of Singapore.
|
⯀
|
to any legal entity which is a qualified investor as defined in Article 2 of the UK Prospectus Regulation;
|
⯀
|
to fewer than 150 natural or legal persons (other than qualified investors as defined in Article 2 of the UK Prospectus Regulation), subject to obtaining the prior consent of the representatives for any such offer; or
|
⯀
|
in any other circumstances falling within Section 86 of the Financial Services and Markets Act 2000 (“FSMA”),
|
ASSETS
|
| |
|
Current asset – cash
|
| |
$25,000
|
Deferred offering costs
|
| |
50,000
|
Total Assets
|
| |
$75,000
|
|
| |
|
LIABILITIES AND STOCKHOLDER’S EQUITY
|
| |
|
Current liabilities
|
| |
|
Accrued expenses
|
| |
1,000
|
Accrued offering costs
|
| |
50,000
|
Total Liabilities
|
| |
51,000
|
|
| |
|
Commitments
|
| |
|
|
| |
|
Stockholder’s Equity
|
| |
|
Preferred stock, $0.0001 par value; 1,000,000 shares authorized, none issued and outstanding
|
| |
—
|
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; none issued and outstanding
|
| |
—
|
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 5,750,000 shares issued and outstanding(1)
|
| |
575
|
Additional paid-in capital
|
| |
24,425
|
Accumulated deficit
|
| |
(1,000)
|
Total Stockholder’s Equity
|
| |
24,000
|
Total Liabilities and Stockholder’s Equity
|
| |
$75,000
|
(1)
|
Includes up to 750,000 Class B shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 5).
|
Formation costs
|
| |
$1,000
|
Net loss
|
| |
$(1,000)
|
|
| |
|
Weighted average shares outstanding, basic and diluted(1)
|
| |
5,000,000
|
Basic and diluted net loss per common share
|
| |
$(0.00)
|
(1)
|
Excludes up to 750,000 Class B shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 5).
|
|
| |
Class B
Common Stock(1)
|
| |
Additional
Paid-in
Capital
|
| |
Accumulated
Deficit
|
| |
Stockholder’s
Equity
|
|||
|
| |
Shares
|
| |
Amount
|
| ||||||||
Balance – January 5, 2021 (Inception)
|
| |
—
|
| |
$—
|
| |
$—
|
| |
$—
|
| |
$—
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
Issuance of Class B common stock to Sponsor(1)
|
| |
5,750,000
|
| |
575
|
| |
24,425
|
| |
—
|
| |
25,000
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
Net loss
|
| |
—
|
| |
—
|
| |
—
|
| |
(1,000)
|
| |
(1,000)
|
Balance – January 22, 2021
|
| |
5,750,000
|
| |
$575
|
| |
$24,425
|
| |
$(1,000)
|
| |
$24,000
|
(1)
|
Includes up to 750,000 Class B shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 5).
|
Cash flows from Operating Activities:
|
| |
|
Net loss
|
| |
$(1,000)
|
Changes in operating assets and liabilities:
|
| |
|
Accrued expenses
|
| |
1,000
|
Net cash used in operating activities
|
| |
—
|
|
| |
|
Cash Flows from Financing Activities:
|
| |
|
Proceeds from issuance of Class B common stock to Sponsor
|
| |
25,000
|
Net cash provided by financing activities
|
| |
25,000
|
|
| |
|
Net Change in Cash
|
| |
25,000
|
Cash – Beginning
|
| |
—
|
Cash – Ending
|
| |
$25,000
|
|
| |
|
Supplemental disclosure of non-cash investing and financing activities:
|
| |
|
Deferred offering costs included in accrued offering costs
|
| |
$50,000
|
⯀
|
in whole and not in part;
|
⯀
|
at a price of $0.01 per Public Warrant;
|
⯀
|
upon not less than 30 days' prior written notice of redemption to each warrant holder; and
|
⯀
|
if, and only if, the reported closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three business days before we send the notice of redemption to the warrant holders.
|
⯀
|
in whole and not in part;
|
⯀
|
at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the fair market value of the Class A common stock;
|
⯀
|
if, and only if, the closing price of Class A common stock equals or exceeds $10.00 per Public Share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within the 30-trading day period ending three trading days before notice of redemption is sent to the warrant holders; and
|
⯀
|
if the closing price of Class A common stock for any 20 trading days within a 30-trading day period ending three trading days before notice of redemption is sent to the warrant holders is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above.
|
Item 13.
|
Other Expenses of Issuance and Distribution.
|
Legal fees and expenses
|
| |
225,000
|
Accounting fees and expenses
|
| |
40,000
|
SEC/FINRA Expenses
|
| |
60,093
|
Travel and road show
|
| |
20,000
|
Nasdaq listing and filing fees
|
| |
75,000
|
Director and Officer liability insurance premiums(1)
|
| |
375,000
|
Printing and engraving expenses
|
| |
40,000
|
Miscellaneous expenses
|
| |
164,907
|
Total offering expenses
|
| |
$1,000,000
|
(1)
|
This amount represents the approximate amount of annual director and officer liability insurance premiums the registrant anticipates paying following the completion of its initial public offering and until it completes an initial business combination.
|
Item 14.
|
Indemnification of Directors and officers.
|
(a)
|
A corporation shall have power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation) by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person’s conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that the person’s conduct was unlawful.
|
(b)
|
A corporation shall have power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses (including attorneys’ fees) actually and reasonably incurred by the person in connection with the defense or settlement of such action or suit if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation and except that no indemnification shall be made in respect of
|
(c)
|
To the extent that a present or former director or officer of a corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in subsections (a) and (b) of this section, or in defense of any claim, issue or matter therein, such person shall be indemnified against expenses (including attorneys’ fees) actually and reasonably incurred by such person in connection therewith.
|
(d)
|
Any indemnification under subsections (a) and (b) of this section (unless ordered by a court) shall be made by the corporation only as authorized in the specific case upon a determination that indemnification of the present or former director, officer, employee or agent is proper in the circumstances because the person has met the applicable standard of conduct set forth in subsections (a) and (b) of this section. Such determination shall be made, with respect to a person who is a director or officer at the time of such determination, (1) by a majority vote of the directors who are not parties to such action, suit or proceeding, even though less than a quorum, or (2) by a committee of such directors designated by majority vote of such directors, even though less than a quorum, or (3) if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion, or (4) by the stockholders.
|
(e)
|
Expenses (including attorneys’ fees) incurred by an officer or director in defending any civil, criminal, administrative or investigative action, suit or proceeding may be paid by the corporation in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it shall ultimately be determined that such person is not entitled to be indemnified by the corporation as authorized in this section. Such expenses (including attorneys’ fees) incurred by former officers and directors or other employees and agents may be so paid upon such terms and conditions, if any, as the corporation deems appropriate.
|
(f)
|
The indemnification and advancement of expenses provided by, or granted pursuant to, the other subsections of this section shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such person’s official capacity and as to action in another capacity while holding such office. A right to indemnification or to advancement of expenses arising under a provision of the certificate of incorporation or a bylaw shall not be eliminated or impaired by an amendment to such provision after the occurrence of the act or omission that is the subject of the civil, criminal, administrative or investigative action, suit or proceeding for which indemnification or advancement of expenses is sought, unless the provision in effect at the time of such act or omission explicitly authorizes such elimination or impairment after such action or omission has occurred.
|
(g)
|
A corporation shall have power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person and incurred by such person in any such capacity, or arising out of such person’s status as such, whether or not the corporation would have the power to indemnify such person against such liability under this section.
|
(h)
|
For purposes of this section, references to “the corporation” shall include, in addition to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, and employees or agents, so that any person who is or was a director, officer, employee or agent of such constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, shall stand in the same position under this section with respect to the resulting or surviving corporation as such person would have with respect to such constituent corporation if its separate existence had continued.
|
(i)
|
For purposes of this section, references to “other enterprises” shall include employee benefit plans; references to “fines” shall include any excise taxes assessed on a person with respect to any employee benefit plan; and references to “serving at the request of the corporation” shall include any service as a director, officer, employee or agent of the corporation which imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner such person reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner “not opposed to the best interests of the corporation” as referred to in this section.
|
(j)
|
The indemnification and advancement of expenses provided by, or granted pursuant to, this section shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the heirs, executors and administrators of such a person.
|
(k)
|
The Court of Chancery is hereby vested with exclusive jurisdiction to hear and determine all actions for advancement of expenses or indemnification brought under this section or under any by law, agreement, vote of stockholders or disinterested directors, or otherwise. The Court of Chancery may summarily determine a corporation’s obligation to advance expenses (including attorneys’ fees).
|
Item 15.
|
Recent Sales of Unregistered Securities.
|
Item 16.
|
Exhibits and Financial Statement Schedules.
|
(a)
|
Exhibits. The list of exhibits preceding the signature page of this registration statement is incorporated herein by reference.
|
(b)
|
Financial Statements. See page F-1 for an index to the financial statements and schedules included in the registration statement.
|
Item 17.
|
Undertakings.
|
(a)
|
The undersigned registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreements, certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser.
|
(b)
|
Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.
|
(c)
|
The undersigned registrant hereby undertakes that:
|
(1)
|
For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.
|
(2)
|
For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
|
Exhibit
|
| |
Description
|
1.1
|
| |
Form of Underwriting Agreement**
|
3.1
|
| |
Certificate of Incorporation**
|
3.2
|
| |
Form of Amended and Restated Certificate of Incorporation**
|
3.3
|
| |
By Laws**
|
4.1
|
| |
Specimen Unit Certificate**
|
4.2
|
| |
Specimen Class A Common Stock Certificate**
|
4.3
|
| |
Specimen Warrant Certificate**
|
4.4
|
| |
Form of Warrant Agreement between Continental Stock Transfer & Trust Company, LLC and the Registrant**
|
5.1
|
| |
Opinion of Kirkland & Ellis LLP**
|
10.1
|
| |
Form of Letter Agreement among the Registrant and our officers directors and sponsor**
|
| |
Promissory Note, dated January 22, 2021, issued to the sponsor*
|
|
10.4
|
| |
Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company, LLC and the Registrant**
|
10.5
|
| |
Form of Registration Rights Agreement between the Registrant and certain security holders**
|
| |
Securities Subscription Agreement, dated January 22, 2021, between the Registrant and the sponsor*
|
|
10.7
|
| |
Form of Private Placement Warrants Purchase Agreement between the Registrant and the sponsor**
|
10.8
|
| |
Form of Indemnity Agreement**
|
10.9
|
| |
Form of Administrative Support Agreement between the Registrant and Software Acquisition Holdings III, LLC**
|
14.1
|
| |
Form of Code of Ethics**
|
| |
Consent of Marcum LLP*
|
|
23.2
|
| |
Consent of Kirkland & Ellis LLP (included in Exhibit 5.1)**
|
99.1
|
| |
Form of Audit Committee Charter**
|
99.2
|
| |
Form of Compensation Committee Charter**
|
99.3
|
| |
Form of Nominating and Corporate Governance Charter**
|
| |
Consent of Andrew Nikou*
|
|
| |
Consent of C. Matthew Olton*
|
|
| |
Consent of Stephanie Davis*
|
|
| |
Consent of Steven Guggenheimer*
|
|
| |
Consent of Dr. Peter H. Diamandis*
|
|
| |
Consent of Mike Nikzad*
|
|
| |
SOFTWARE ACQUISITION GROUP INC. III
|
|||
|
| |
|
| |
|
|
| |
By:
|
| |
/s/ Jonathan S. Huberman
|
|
| |
|
| |
Jonathan S. Huberman
|
|
| |
|
| |
Chief Executive Officer
|
Name
|
| |
Position
|
| |
Date
|
/s/ Jonathan S. Huberman
|
| |
Chief Executive Officer, Chief Financial Officer and Chairman of the “Board and Director
(principal executive officer, principal financial officer and principal accounting officer)
|
| |
February 17, 2021
|
Jonathan S. Huberman
|
|
Principal Amount: Up to $300,000
|
Dated as of January 22, 2021
|
New York, New York
|
SOFTWARE ACQUISITION GROUP INC. III
|
||
By:
|
/s/ Jonathan S. Huberman
|
|
Name:
|
Jonathan S. Huberman
|
|
Title:
|
Chief Executive Officer
|
Very truly yours,
|
||
SOFTWARE ACQUISITION HOLDINGS III LLC
|
||
By:
|
/s/ Jonathan S. Huberman
|
|
Name:
|
Jonathan S. Huberman
|
|
Title:
|
Chief Executive Officer
|
By:
|
/s/ Jonathan S. Huberman
|
|
Name:
|
Jonathan S. Huberman
|
|
Title:
|
Managing Member
|